Estabrook Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22M Sell
89,857
-236
-0.3% -$55K 3.21% 5
2025
Q4
$18.6M Sell
90,093
-1,420
-2% -$281K 2.74% 7
2025
Q3
$17M Sell
91,513
-241
-0.3% -$41.3K 2.47% 7
2025
Q2
$14M Buy
91,754
+338
+0.4% +$52K 2.16% 8
2025
Q1
$15.2M Sell
91,416
-1,948
-2% -$305K 2.45% 7
2024
Q4
$13.5M Sell
93,364
-1,222
-1% -$189K 2.08% 11
2024
Q3
$15.3M Sell
94,586
-660
-0.7% -$105K 2.29% 8
2024
Q2
$13.9M Sell
95,246
-578
-0.6% -$86K 2.14% 9
2024
Q1
$15.2M Sell
95,824
-205
-0.2% -$32.6K 2.34% 8
2023
Q4
$15.1M Sell
96,029
-1,037
-1% -$159K 2.46% 8
2023
Q3
$15.1M Buy
97,066
+297
+0.3% +$49K 2.66% 6
2023
Q2
$16M Sell
96,769
-107
-0.1% -$17.3K 2.67% 6
2023
Q1
$15M Sell
96,876
-175
-0.2% -$28.3K 2.61% 6
2022
Q4
$17.1M Sell
97,051
-860
-0.9% -$148K 2.95% 6
2022
Q3
$16M Sell
97,911
-1,489
-1% -$252K 2.97% 5
2022
Q2
$17.6M Sell
99,400
-1,804
-2% -$321K 3.02% 5
2022
Q1
$17.9M Sell
101,204
-287
-0.3% -$48.8K 2.64% 6
2021
Q4
$17.4M Buy
101,491
+353
+0.3% +$57.8K 2.46% 9
2021
Q3
$16.3M Sell
101,138
-1,573
-2% -$268K 2.57% 7
2021
Q2
$16.9M Sell
102,711
-935
-0.9% -$155K 2.57% 8
2021
Q1
$17M Buy
103,646
+2,542
+3% +$411K 2.62% 9
2020
Q4
$15.9M Sell
101,104
-2,568
-2% -$379K 2.64% 7
2020
Q3
$15.4M Sell
103,672
-1,747
-2% -$259K 2.83% 8
2020
Q2
$14.8M Sell
105,419
-3,927
-4% -$572K 2.82% 7
2020
Q1
$14.3M Sell
109,346
-4,836
-4% -$686K 3.02% 6
2019
Q4
$16.7M Sell
114,182
-1,529
-1% -$207K 2.5% 11
2019
Q3
$15M Sell
115,711
-4,412
-4% -$581K 2.5% 12
2019
Q2
$16.7M Sell
120,123
-1,040
-0.9% -$144K 2.74% 8
2019
Q1
$16.9M Buy
121,163
+717
+0.6% +$96K 2.81% 9
2018
Q4
$15.5M Sell
120,446
-3,324
-3% -$464K 2.88% 6
2018
Q3
$17.1M Buy
123,770
+246
+0.2% +$32.7K 2.59% 11
2018
Q2
$15M Sell
123,524
-2,731
-2% -$341K 2.36% 13
2018
Q1
$16.2M Sell
126,255
-1,135
-0.9% -$153K 2.54% 9
2017
Q4
$17.8M Sell
127,390
-2,098
-2% -$292K 2.69% 8
2017
Q3
$16.8M Sell
129,488
-3,429
-3% -$455K 2.62% 9
2017
Q2
$17.6M Sell
132,917
-2,451
-2% -$313K 2.8% 5
2017
Q1
$16.9M Sell
135,368
-8,853
-6% -$1.06M 2.64% 6
2016
Q4
$16.6M Sell
144,221
-13,509
-9% -$1.56M 2.6% 7
2016
Q3
$18.6M Sell
157,730
-4,174
-3% -$506K 2.74% 7
2016
Q2
$19.6M Sell
161,904
-7,481
-4% -$850K 2.94% 5
2016
Q1
$18.3M Sell
169,385
-5,668
-3% -$587K 2.71% 7
2015
Q4
$18M Sell
175,053
-7,431
-4% -$747K 2.6% 11
2015
Q3
$17M Sell
182,484
-7,290
-4% -$705K 2.46% 12
2015
Q2
$18.5M Sell
189,774
-8,735
-4% -$875K 2.29% 15
2015
Q1
$20M Sell
198,509
-4,646
-2% -$472K 2.33% 13
2014
Q4
$21.2M Sell
203,155
-3,198
-2% -$337K 2.34% 12
2014
Q3
$22M Sell
206,353
-6,518
-3% -$676K 2.35% 14
2014
Q2
$22.3M Sell
212,871
-6,948
-3% -$702K 2.29% 15
2014
Q1
$21.6M Sell
219,819
-6,582
-3% -$610K 2.2% 15
2013
Q4
$20.7M Sell
226,401
-7,263
-3% -$669K 2.13% 17
2013
Q3
$20.3M Sell
233,664
-12,683
-5% -$1.14M 2.21% 15
2013
Q2
$21.2M Buy
+246,347
New +$20.9M 2.24% 14

Other funds holding JNJ

Estabrook Capital Management's JNJ Position: Q1 2026 in Review

Estabrook Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.26% in Q1 2026, selling an estimated $55K and leaving 89,857 shares worth $22M. The position accounts for 3.21% of the portfolio, ranked #5.

Estabrook Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.3M in Q2 2014. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Estabrook Capital Management held 89,857 shares of Johnson & Johnson worth $22M as of Q1 2026.
  • Estabrook Capital Management sold 236 Johnson & Johnson shares in Q1 2026, an estimated $55K.
  • Johnson & Johnson made up 3.21% of Estabrook Capital Management's portfolio in Q1 2026, its #5 holding.
  • Estabrook Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Estabrook Capital Management's Johnson & Johnson position peaked at $22.3M in Q2 2014.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.